跳至主要内容
临床试验/IRCT2017012532186N1
IRCT2017012532186N1已完成2 期

The effect of melatonin treatment in patients with Irritable Bowel Syndrome (IBS)

Vice chancellor for research, Arak University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Irritable Bowel Syndrome (IBS) based on Rome III criteria; Lack of comorbidity including anemia, blood in the stool, significant weight loss, nocturnal diarrhea, Inflammatory Bowel Disease (IBD); previous abdominal surgery; diabetes; thyroid disorders; do not use antibiotic in the last month; do not take drug for IBS treating in the last month.
  • Exclusion criteria: lack of patient collaboration; drug addiction; any risk of heart disease; neurological and psychological disorder; gastrointestinal and liver disease; pregnancy; any kind of malignancy

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Arak University of Medical Sciences

相似试验

The effect of melatonin treatment in patients with... | 临床试验